Cargando…
Expression of Influenza M2e-NP Recombinant Fusion Protein in Escherichia coli BL21 (DE3) and Its Binding to Antibodies
The current influenza vaccines only confer protection against the circulating influenza subtypes, therefore universal vaccines are needed to prevent upcoming influenza outbreaks caused by emerging influenza subtypes. The extracellular domain of influenza A M2 protein (M2e) is highly conserved among...
Autores principales: | Tan, Mei Peng, Mohamed Alitheen, Noorjahan Banu, Tan, Wen Siang, Yap, Wei Boon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784878/ https://www.ncbi.nlm.nih.gov/pubmed/36560475 http://dx.doi.org/10.3390/vaccines10122066 |
Ejemplares similares
-
M2e-Based Influenza Vaccines with Nucleoprotein: A Review
por: Tan, Mei Peng, et al.
Publicado: (2021) -
Impact of the Expression System on Recombinant Protein Production in Escherichia coli BL21
por: Lozano Terol, Gema, et al.
Publicado: (2021) -
Transcriptional profiling of thymidine-producing strain recombineered from Escherichia coli BL21
por: Kim, Jin-Sook, et al.
Publicado: (2015) -
Enhancing the biosynthesis of riboflavin in the recombinant Escherichia coli BL21 strain by metabolic engineering
por: Fu, Bing, et al.
Publicado: (2023) -
Purity of maltose-binding protein – Recombinant streptavidin expressed in Escherichia coli BL21 (pD861-MBP: 327892)
por: Subroto, Toto, et al.
Publicado: (2022)